Early versus delayed anticoagulation treatment for people with non-valvular atrial fibrillation-related acute ischaemic stroke

source extracted confidence: high 2026-04-09
#humans #anticoagulants #atrial-fibrillation #ischemic-stroke #randomized-controlled-trials-as-topic

Early versus delayed anticoagulation treatment for people with non-valvular atrial fibrillation-related acute ischaemic stroke

Zhang et al., 2025 | Cochrane Database Syst Rev | Other

Citation

Zhang Xiaodan, Ng Timothy Kar Yip, ... Rainer Timothy Hudson. Early versus delayed anticoagulation treatment for people with non-valvular atrial fibrillation-related acute ischaemic stroke. Cochrane Database Syst Rev. 2025-Jan-08;1(1):CD016045. doi:10.1002/14651858.CD016045

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and risks of early versus late initiation of oral anticoagulation (vitamin K antagonists or NOACs) in people with non-valvular atrial fibrillation-related ischaemic stroke.

Key Findings

The objectives are as follows: To assess the benefits and risks of early versus late initiation of oral anticoagulation (vitamin K antagonists or NOACs) in people with non-valvular atrial fibrillation-related ischaemic stroke.

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Humans
  • Anticoagulants
  • Atrial Fibrillation
  • Ischemic Stroke
  • Randomized Controlled Trials as Topic
  • Systematic Reviews as Topic
  • Time Factors
  • Time-to-Treatment
  • Vitamin K

Evidence Classification

  • Level: Other
  • Publication Types: Journal Article
  • Vertical: vitamin-k

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09